Biohit group financial statement release 2020
Biohit Oyj Financial Statement Release 17 February 2021 at 9:30 am local time (EET) SUMMARY January-December 2020 ·Revenue EUR 7.1 million (EUR 10.1 million) · Revenue decreased by 29.1 % compared to 2019 · Operative EBITDA EUR -1.2 million (EUR +0.6 million) · Cash at the end of the period EUR 1.0 million (EUR 1.3 million) · Fair value of Genetic Analysis AS investment EUR 0.8 million (EUR 3.7 million 31 December 2019) · Revenue from international operations 96.1 % (96.0 %) of total revenue · Equity ratio 80.8 % (83.9 %) July-December 2020 ·